Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study
The PASCUAL study evaluating a prostate cancer assay sponsored by MDx Health has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy [EARLY_Phase 1]
This clinical trial update notes the completion of an EARLY_PHASE1 study evaluating vismodegib in men with metastatic castration-resistant p…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating IMC-A12 (Cixutumumab) in metastatic prostate cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive [Phase 2]
Phase 2 trial comparing ipilimumab 3 mg/kg vs 10 mg/kg in chemotherapy-naive metastatic castration-resistant prostate cancer; results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. [Phase 2]
A Phase 2 clinical trial evaluating Vitamin D3 (cholecalciferol) supplementation in men with early-stage prostate cancer choosing active sur…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating two doses of MPX capsules on rising PSA after initial therapy in prostate cancer patients; study complet…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer [Phase 2]
Phase 2 trial update of Provenge (sipuleucel-T) with or without pTVG-HP DNA booster vaccine in prostate cancer completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating gefitinib and etoposide in advanced prostate cancer resistant to hormone therapy; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer [Phase 1]
A Phase 1 study evaluated allogeneic human bone marrow-derived mesenchymal stem cells in localized prostate cancer. The trial has been termi…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer [Phase 1, Phase 2]
Phase Ib/IIa trial evaluating cabazitaxel plus bavituximab in castration-resistant prostate cancer was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery [NA]
This update notes that the Dana-Farber Cancer Institute's trial evaluating polyunsaturated fatty acids in men with prostate cancer undergoin…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 clinical trial update for enzalutamide in nonmetastatic castration-resistant prostate cancer; the study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone [Phase 2]
Phase 2 trial comparing standard dose, high dose, and extended standard dose of Radium-223 dichloride in metastatic castration-resistant pro…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Intraprostatic MAXimal Simultaneous Boost [NA]
This clinical trial update reports that the intraprostatic maximal simultaneous boost trial in prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency [Phase 3]
An ongoing Phase 3 clinical trial is evaluating Everolimus in castration-resistant prostate cancer patients who have deficiencies in the PI3…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer [Phase 1]
Phase 1 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node involvement in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT [EARLY_Phase 1]
First-in-human biodistribution study of the radiotracer [F-18]FMDHT in healthy volunteers and patients with metastatic prostate cancer. The …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer [Phase 1]
A Phase 1 study assessing C-11 choline PET-CT imaging to detect metastases in men with newly diagnosed high-risk prostate cancer has been co…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy [Phase 1]
This Phase 1 study of veliparib in patients with malignant solid tumors that did not respond to prior therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy [NA]
Clinical trial update on robotic template guidance for needle placement in transperineal prostate brachytherapy has completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer [NA]
A clinical trial using microspheres to prevent lymphatic fluid collection after prostate cancer surgery was terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial update of Selinexor in patients with abiraterone and/or enzalutamide refractory metastatic castration-resistant prostate cance…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma [Phase 3]
Phase 3 clinical trial update on chemotherapy after prostatectomy for high-risk prostate cancer, with results posted on 2018-06-25.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment [Phase 2]
A Phase 2 study evaluating the combination of docetaxel, estramustine, and short-term androgen withdrawal in patients with rising PSA after …